IASLC

Lung Cancer Considered

Science EN ↓ 425 episodes

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...

Be sure to visit the podcast's website and support the creator: www.iaslc.org

Author

IASLC

Category

Science

Podcast website

www.iaslc.org

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Breakthrough Therapies- HER2 with Dr. Bob T. Li 17.08.2021

About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.

Virtual Tumor Board: NSCLC/Metastatic KRAS G12V with Misako Nagasaka and Antonio Passaro 04.08.2021

In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests Dr. Misako Nagasaka and Dr. Antonio Passaro discuss management of a Stage IV non-small cell lung cancer in this Virtual Tumor Board case study.

Career Paths with Dr. Tom John 20.07.2021

In this special musical edition of Lung Cancer Considered, Host Stephen Liu talks with physician-researcher and musician Dr. Thomas John from Melbourne, Australia. We think you’ll want to tune in and listen to the end as Dr. John, performing as Mayhemtom, shares his new single called ‘Reach Out’ from the album he is currently producing. The single is now available at: https://linktr.ee/mayhemtom R...

Lung Cancer in Italy - In Italian: Dr. Marina Garissino and Dr. Silvia Novello 30.06.2021

In this special Italian-language edition of Lung Cancer Considered, host Dr. Alfredo Addeo examines lung cancer in Italy with Dr. Marina Garissino and Dr. Silvia Novello. The researchers discuss their thoughts on navigating a career as women oncologists in Italy and compare their perceptions about the differences in lung cancer screening and research between Italy and other countries.

Financial Toxicity with Dr. Fumiko Chino 15.06.2021

In this edition of Lung Cancer Considered, host Narjust Duma and Dr. Fumiko Chino discuss a challenge to thoracic oncology which is financial toxicity associated with cancer care. The two women dive into the complexity of health insurance and the multifactorial situations that are associated with the care a patient receives. Dr. Chino also reveals her personal experience with financial toxicity an...

ASCO 2021 Highlights with Dr. Heather Wakelee and Dr. Alfredo Addeo 10.06.2021

The American Society of Clinical Oncology meeting just concluded and Lung Cancer Considered has a summary of the meeting, with a unique lung cancer focus. Tune in as host Stephen Liu and guests Dr. Alfredo Addeo and Dr. Heather Wakelee discuss key findings from ASCO 2021.

Neoadjuvant IO with Patrick Forde and Leah Backhus 07.06.2021

In this edition of Lung Cancer Considered, host Dr. Narjust Duma discusses the use of neoadjuvant immunotherapy, through a multidisciplinary lens, with guests Dr. Leah Backhus and Dr. Patrick Forde.

FDA with Dr. Harpreet Singh 01.06.2021

In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how new drug approvals are handled in other countries

Virtual Tumor Board: NSCLC - Higgins and Calles 17.05.2021

In this episode of Lung Cancer Considered, guests Dr. Kristin A. Higgins and Dr. Antonio Calles discuss the case of a 42-year-old woman who presents to the emergency room with right shoulder pain and a dry cough that has worsened over the previous two months. A CT scan reveals she has a four-centimeter mass in her right lobe. Her PDL-1 is 1-2 percent. She has a limited history of smoking but no co...

Seminal Trials Series - KEYNOTE 001 with Dr Edward Garon and Cary Parton: Patient Input 11.05.2021

This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients with lung cancer. This podcast is noteworthy because, in addition to including researcher Dr. Eddie Garon, it also features the unique perspective from Cary Parton, a patient who participated in this trial.

KRAS G12C Mutation with Dr. Tetsuya Mitsudomi 03.05.2021

This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.

Tumor Board Discussion: Mesothelioma - Nowak and Mansfield 19.04.2021

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board in mesothelioma, involving a case with a 68-year-old male, with 30 pack years smoking history who presents to the ER due to a worsening shortness of breath at rest and with exertion, unresectable mesothelioma with chest wall invasion and pleural effusion thickening with enlarged mediastinal lymph nodes and...

Breakthrough Therapies - ALK with Dr. Ignatius Ou 12.04.2021

In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examini...

ELCC Highlights - Felip and Barlesi 05.04.2021

This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC: Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy co...

Tumor Board Discussion- Paik and Felip 15.03.2021

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board case involving squamous cell lung cancer. Our guests are Dr. Enriqueta Felip, who is a professor of medicine and section in chief, Medical Oncology and Department Director of Thoracic Oncology at the Vall d’Hebron University Hospital in Barcelona. Joining Dr. Felip is Dr. Paul Paik, an associate attending p...

Developing the Moderna COVID-19 Vaccine 08.03.2021

This special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore s...

ROS1 Lung Cancer with Dr. Myung-Ju Ahn 01.03.2021

The latest episode of Lung Cancer Considered features a conversation between host, Dr. Stephen Liu and Dr. Myung-Ju Ahn, professor in the Department of Hematology-Oncology at the Samsung Medical Center, Sungkyunkwan University School of Medicine in South Korea. Together they discuss Dr. Ahn's career and her work in ROS1 lung cancer.

RET Fusions in Lung Cancer with Dr. Alex Drilon 17.02.2021

The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.

EGFR Resistance and Beyond with Dr. Balazs Halmos 15.02.2021

The latest episode of Lung Cancer Considered features a conversation between host Dr. Narjust Duma and Dr. Balazs Halmos, professor of oncology and chief, thoracic/head and neck oncology at Montefiore Medical Center/Albert Einstein College of Medicine in New York. Together they discuss Dr. Halmos' career and his work on EGFR mutant non-small cell lung cancer.

WCLC 2020 Highlights and Wrap-Up 02.02.2021

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma are joined by Dr. Ross Soo, a senior consultant in the Department of Hematology-Oncology at the National University of Cancer Institute Singapore to discuss highlights from the IASLC 2020 WCLC Singapore meeting. Dr. Soo, along with Dr. Yi-Long Wu and Dr. Daniel Tan, served as co-chair of the meeting. Together Dr. Liu, Dr. Duma and D...

Tips and Tricks for Navigating IASLC WCLC 18.01.2021

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma share highlights, tips and tricks for navigating IASLC's World Conference on Lung Cancer Singapore this year. Listen to this podcast as you prepare for the world’s leading lung cancer event (held virtually January 28 – 31). Register for IASLC's WCLC at //wclc2020.iaslc.org/registration.

Women In Thoracic Oncology 12.01.2021

The latest episode of Lung Cancer Considered discusses women in thoracic oncology and the upcoming IASLC Women in Thoracic Oncology Event. Register now for this event. This episode features a conversation between host, Dr. Narjust Duma, and Dr. Heather Wakelee and Dr. Clarissa Mathias. Dr. Wakelee is a thoracic medical oncologist, Deputy Director of the Stanford Cancer Institute and is the Divisio...

Lung Cancer Considered Introduces New Podcast Hosts 04.01.2021

The latest episode of Lung Cancer Considered introduces its new hosts, Dr. Stephen Liu and Dr. Narjust Duma. Dr. Liu is an associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine. Dr. Duma is an assistant professor of medicine and a thoracic oncologist at the University of Wisconsin. Get to know both Dr. Liu and Dr. Duma a little more and hear what their goals...

Biological/Molecular Staging with Dr. Daniel Boffa 21.12.2020

The latest episode of Lung Cancer Considered discusses biological and molecular staging as a dimension beyond sized-based staging. This episode features a conversation between host Dr. Jack West and Dr. Daniel Boffa, professor and division chief of thoracic surgery at Yale University.

Practicing Medicine and Obtaining Treatments in Low & Middle-Income Countries 07.12.2020

The latest episode of “Lung Cancer Considered” discusses the practice patterns and clinical trials in India and how COVID-19 has impacted the field in India. This episode features a conversation between host Dr. Jack West and Dr. Vanita Noronha, professor of medical oncology at Tata Memorial Hospital, Mumbai, India.

Listen to the Lung Cancer Considered podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.